Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00682_DB00712_nanopub.RAOsxl4MP03oTpIsbF1soxygG2pKmk2u0GHnyUKDSbEIA#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00682_DB00712 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00682_DB00712 label "DDI between Warfarin and Flurbiprofen - Flurbiprofen, a strong CYP2C9 inhibitor, may decrease the metabolism of warfarin. The antiplatelet effect of flurbiprofen may also increase the bleed risk associated with warfarin. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of warfarin if flurbiprofen is initiated, discontinued or dose changed. [drugbank_resource:DB00682_DB00712]" assertion.
- drugbank_resource:DB00682_DB00712 identifier "drugbank_resource:DB00682_DB00712" assertion.
- drugbank_resource:DB00682_DB00712 title "DDI between Warfarin and Flurbiprofen - Flurbiprofen, a strong CYP2C9 inhibitor, may decrease the metabolism of warfarin. The antiplatelet effect of flurbiprofen may also increase the bleed risk associated with warfarin. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of warfarin if flurbiprofen is initiated, discontinued or dose changed." assertion.
- drugbank:DB00682 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00682_DB00712 assertion.
- drugbank:DB00712 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00682_DB00712 assertion.